lundi 5 octobre 2015

Onco Actu du 5 octobre 2015

2. Etiologie

Too soon to say being tall increases cancer risk [NHS Choices]

3.1 Tabac

UK smoking rate nears record low [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Prevention better than cure, says NICE Chair [NICE]

4.12 Biopsies liquides

“Liquid biopsies” for cancer: not ready for prime time [Respectful Insolence]

4.5 Dép., diag. & prono. - Colorectal

Researcher calls for changes to colon cancer screening guidelines [UPI]

5. Traitements

Blood cells offer new camouflage for cancer drugs [PHG Foundation]

5.2.3 Pharma - économie

Pfizer Raised Prices on 133 Drugs This Year, And It's Not Alone [Bloomberg]

5.3.4 Traitements - AMM (FDA, EMA)

Merck's Keytruda snags FDA approval for NSCLC, but label is narrow [FiercePharma]

FDA Approves KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy [Merck]

FDA expands approval of Merck's Keytruda to lung cancer [Reuters]

FDA approves Keytruda for advanced non-small cell lung cancer [FDA]

6.1 Observation

Gleevec: What’s Next for the Leukemias? [Clinical Oncology News]

6.11 Patients

Doctors told me I was cancer free, then said it had spread moments later [The Telegraph]

6.4 Médico-éco

GP practices 'offered rewards' for not referring patients to hospitals [The Guardian]

GPs being paid to cut patient referrals [BBC News]

Our NHS is in serious danger – we should be scandalised [The Guardian]

6.8 Communication

Many UK doctors have a negative view of the pharmaceutical industry [Pharmalot]